BYAM REBECCA (Chief Financial Officer) purchased 0.9% of their position (5K shares) of HCW BIOLOGICS INC. on the open market
Open‑market purchase worth $9.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/7/2023ACC: 0001209191-23-048651
Officer· Chief Financial Officer
Since Jul 2021
+5K
Net shares
Net buyer
$9.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.95
Trade value
$9.75K
% of position
0.9%
9/6/2023
543.95K→548.95K
Total
Net shares
+5K
Net value
$9.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/6/2023 | P · Purchase | +5K | $1.95 | $9.75K | 0.9% | 543.95K | 548.95K |
| Total | +5K | $9.75K | ||||||
Derivative Transactions0
No derivative transactions reported